Marc R. Larochelle MD, MPH
Associate Professor, General Internal Medicine
801 Massachusetts Ave | (617) 414-7399marc.larochelle@bmc.org
marcl@bu.edu
Sections
General Internal Medicine
Centers
Clinical Addiction Research and Education Unit
Biography
Marc Larochelle is a general internist and clinical investigator specializing in addiction medicine at BMC and an assistant professor of medicine at BUSM. Larochelle's clinical and research interests focus on the safety of opioid prescribing and the recognition and treatment of opioid use disorders. As a health services researcher, Larochelle aims to leverage insights from large data sources and translate the findings into interventions that improve the quality and value of health care delivered. His special interests are Primary Care and Addiction Medicine.
Education
Medicine-Internal, MD, University of Pittsburgh School of Medicine
Clinical Evaluation/Research, MPH, Harvard School of Public Health
Biomedical Engineering, BSE, Duke University
Publications
Gilbert L, Chahine R, Chandler R, Feaster DJ, Kim E, Aldridge A, Bagley S, Balvanz P, Fernandez S, Rock P, Vickers-Smith RA, Villani J, Battaglia T, Brown J, Bush H, Chase RP, Collins T, D'Costa L, Damato-MacPherson C, David JL, Defiore-Hyrmer J, Freeman PR, Glasgow L, Hammerslag LR, Hotchkiss J, Hunt T, Hussain S, Kamanu V, Knott C, Knudsen HK, LaRochelle M, Laudate A, Lyons M, McMullan J, Nakayima J, Schackman BR, Slavova S, Tan S, Vandergrift N, Walters ST, Westgate PM, Wu E, Young AM, Zarkin GA, Freisthler B, Oga E, Samet JH, Walsh SL, Winhusen J, Jackson R, El-Bassel N. The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial. Int J Drug Policy. 2025 Apr 11; 140:104798. PMID: 40220509.
Published on 3/19/2025Lodi S, Yan S, Bovell-Ammon B, Christine PJ, Hsu HE, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz JM, Walley AY, Larochelle MR. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data. Addiction. 2025 Mar 19. PMID: 40104887.
Published on 2/28/2025Tilhou AS, Gasman S, Wang J, Standish K, White LF, Cogan A, Devlin M, Larochelle M, Adams WG. Assessing inequities in buprenorphine treatment across the care cascade. Drug Alcohol Depend. 2025 May 01; 270:112636. PMID: 40043350.
Published on 2/9/2025Bayly R, Cordes J, Bernson D, Ackerson LK, LaRochelle MR, Hassan GH, Bauer CX, Stopka TJ. Predicting fatal opioid-involved overdoses: A social-ecological framework matched to a linked-data warehouse. Int J Drug Policy. 2025 Mar; 137:104730. PMID: 39929056.
Published on 2/5/2025Magane KM, Saitz R, Fielman S, LaRochelle MR, Shanahan CW, Pace CA, LaValley M, Penington K, Karzhevsky S, Hurstak E. Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial. Addict Sci Clin Pract. 2025 Feb 05; 20(1):9. PMID: 39910606.
Published on 11/8/2024Rosenmoss S, LaRochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, Yan S, Walley AY, Kimmel SD. Racial and Ethnic Disparities in Referral Rejection From Postacute Care Facilities Among People With Opioid Use Disorder in Massachusetts. J Addict Med. 2025 Mar-Apr 01; 19(2):165-171. PMID: 39514897.
Published on 9/9/2024Fareed N, Olvera RG, Wang Y, Hayes M, Larimore EL, Balvanz P, Langley R, Noel CA, Rock P, Redmond D, Neufeld J, Kosakowski S, Harris D, LaRochelle M, Huerta TR, Glasgow L, Oga E, Villani J, Wu E. Lessons Learned From Developing Dashboards to Support Decision-Making for Community Opioid Response by Community Stakeholders: Mixed Methods and Multisite Study. JMIR Hum Factors. 2024 Sep 09; 11:e51525. PMID: 39250216.
Published on 8/1/2024Christine PJ, Chahine RA, Kimmel SD, Mack N, Douglas C, Stopka TJ, Calver K, Fanucchi LC, Slavova S, Lofwall M, Feaster DJ, Lyons M, Ezell J, Larochelle MR. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements. JAMA Netw Open. 2024 Aug 01; 7(8):e2425999. PMID: 39102264.
Published on 7/26/2024Sariahmed K, Christine PJ, Wang J, Prifti C, Sabharwal M, LaRochelle M. Medication and procedural abortion uptake during a period of increasing abortion hostility. Soc Sci Med. 2024 Sep; 356:117151. PMID: 39068874.
Published on 7/16/2024Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Receipt of medications for opioid use disorder before and after incarceration in Massachusetts State prisons, 2014-2019. Drug Alcohol Depend. 2024 Sep 01; 262:111392. PMID: 39029371.
Media Mentions
Published on 9/7/2022
Some Patients on Opioids Shouldn’t Have to Taper Off
Published on 8/15/2022
Long-Term Opioid Tapering Does Not Benefit Suicide, Overdose Risks
Published on 9/28/2021
Opioid Overdose Deaths Rise Among Black Americans
Published on 9/20/2021
Opioid Overdose Death Rates Worsening for Non-Hispanic Blacks
Published on 9/17/2021
Opioid Overdose Death Rates Are Rising Among Black Americans
Published on 9/15/2021
How Overdose Surged for Black People as It Held Steady for Whites
Published on 9/15/2021
Researchers Call for Antiracist Approach to Address Disparities In Overdose Deaths
Published on 9/13/2021
Fatal Opioid ODs Keep Rising in Black Americans
Published on 9/13/2021
Fatal Opioid ODs Keep Rising in Black Americans
Published on 9/10/2021
Disparities in Opioid Overdose Deaths Are Worsening for Black Americans
View full list of 28 media mentions.